Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Mihm

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|June 1, 2006
Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis CBernd Kronenberger, Eva Herrmann, W Peter Hofmann, et al.
Journal of Hepatology|February 12, 2011
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpuraGeorg Dultz, Bernd Kronenberger, Alireza Azizi, et al.
Gastroenterology|March 27, 2007
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapyWolf Peter Hofmann, Andreas Polta, Eva Herrmann, et al.
Journal of Hepatology|November 22, 2008
Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis CUlrike Mihm, Oliver Ackermann, Christoph Welsch, et al.
European Journal of Gastroenterology & Hepatology|February 22, 2019
Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infectionsEleni Koukoulioti, Annika Brodzinski, Ulrike Mihm, et al.
Journal of Clinical Medicine|April 12, 2025
Telemedicine Hybrid Care Models in Gastroenterology Outpatient Care: Results from a German Tertiary CenterNada Abedin, Christian Kilbinger, Alexander Queck, et al.
Antiviral Therapy|August 6, 2011
Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevirWolf Peter Hofmann, Tje Lin Chung, Carola Osbahr, et al.
Antiviral Therapy|February 7, 2009
Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis BUlrike Mihm, Henry Lik-Yuen Chan, Stefan Zeuzem, et al.
Hepatology Communications|September 27, 2024
Falls and malnutrition are associated with in-hospital mortality in patients with cirrhosisNada Abedin, Moritz Hein, Alexander Queck, et al.
Antiviral Therapy|July 22, 2006
Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis CUlrike Mihm, Natalia Grigorian, Christoph Welsch, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|June 1, 2006
Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis CBernd Kronenberger, Eva Herrmann, W Peter Hofmann, et al.
Journal of Hepatology|February 12, 2011
Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpuraGeorg Dultz, Bernd Kronenberger, Alireza Azizi, et al.
Gastroenterology|March 27, 2007
Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapyWolf Peter Hofmann, Andreas Polta, Eva Herrmann, et al.
Journal of Hepatology|November 22, 2008
Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis CUlrike Mihm, Oliver Ackermann, Christoph Welsch, et al.
European Journal of Gastroenterology & Hepatology|February 22, 2019
Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infectionsEleni Koukoulioti, Annika Brodzinski, Ulrike Mihm, et al.
Journal of Clinical Medicine|April 12, 2025
Telemedicine Hybrid Care Models in Gastroenterology Outpatient Care: Results from a German Tertiary CenterNada Abedin, Christian Kilbinger, Alexander Queck, et al.
Antiviral Therapy|August 6, 2011
Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevirWolf Peter Hofmann, Tje Lin Chung, Carola Osbahr, et al.
Antiviral Therapy|February 7, 2009
Virodynamic predictors of response to pegylated interferon and lamivudine combination treatment of hepatitis B e antigen-positive chronic hepatitis BUlrike Mihm, Henry Lik-Yuen Chan, Stefan Zeuzem, et al.
Hepatology Communications|September 27, 2024
Falls and malnutrition are associated with in-hospital mortality in patients with cirrhosisNada Abedin, Moritz Hein, Alexander Queck, et al.
Antiviral Therapy|July 22, 2006
Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis CUlrike Mihm, Natalia Grigorian, Christoph Welsch, et al.
Pageof 3